Skip to main content

Humana Value Stock - Dividend - Research Selection

Humana

ISIN: US4448591028 , WKN: 856584

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


UnitedHealth and Humana cutting Medicare Advantage plans in 2027

2026-10-02
CVS Health's Aetna and Centene are also shrinking their Medicare Advantage offerings as insurers pull back from less profitable markets

UnitedHealth Trades at $365 as It Shuts Plans for 390,000 Medicare Advantage Members. Here’s What It Signals for 2027

2026-10-02
Key Stats for UnitedHealth StockCurrent Price: $365. 20Target Price (Mid): ~$586Street Target: ~$482Potential Total Return: ~61%Annualized IRR: ~12% / yearWhat Happened?UnitedHealth Group (UNH:NYSE) is shutting Medicare Advantage plans that cover about 390,000 people for 2027, a company spokesperson told Bloomberg on October 1.

How Much Downside Is Left In CVS Health Stock?

2026-10-02
CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.

Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Got Their Plan-Change Letters Weeks Earlier. Wall Street Got the Numbers in July

2026-10-01
Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.

Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027

2026-10-01
LOUISVILLE, Ky., October 01, 2026--As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Additional 2027 highlights include:

Humana To Offer 2027 Medicare Advantage Plans With Continued Access To The Benefits, Including $0 Cost-Sharing On In-Network Primary Care Visits And Labs Plus Dental, Vision, And Hearing From October 15

2026-10-01
Additional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic Condition Special Needs

What Are UNH Stock Investors Betting On?

2026-09-29
UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.

3 Reasons HUM Has Explosive Upside Potential

2026-09-29
What a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not

2026-09-29
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.

Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?

2026-09-27
Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...